Homoharringtonine-based regimens
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Homoharringtonine-based regimens, covering 2022-09-08 to 2022-09-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML [Phase 2]